Sample Classification | Characterization | Method Development / Validation |
Re-folded Proteins from Pseudomonas inclusion bodies | Y | Y |
Recombinant Glycoprotein | Y | Y |
Chimeric Antibody | Y | Y |
Virus-Like Particles (VLP) | Y | Y |
Acid Inactivated Vaccinia Virus Particle | Y | Y |
Clostridium Difficile Toxin | Y | Y |
Fusion (Chimeric) Proteins | Y | Y |
Recombinant Neuregulin | Y | Y |
Monoclonal Antibody (mAb) | Y | Y |
Recombinant Proteins | Y | Y |
PEGylated Proteins (Lys) | Y | Y |
Poly-lysine matrix incorporating Penicillin | Y | Y |
Poly-lysine matrix incorporating Peptides | Y | Y |
IgG Antibodies | Y | Y |
IgM Antibodies | Y | Y |
Multi-Peptide Therapeutics | Y | Y |
G-Protein Coupled Receptor (GPCRs) | Y | Y |
Botulinum Toxin | Y | Y |
Cross-Linked Hemoglobin Product | Y | Y |
Polyclonal Antibodies | Y | Y |
Recombinant Human Plasma Protein(s) | Y | Y |
Peptide(s) Formulated in Gelatin | Y | Y |
Antibody Drug Conjugates | Y | Y |
Protein Drug Conjugates | Y | Y |
Antibody Peptide Conjugate | Y | Y |
Complex Protein Oligomerization / Scaffolds | Y | Y |
Peptide Crosslinking / Scaffolds | Y | Y |
Biosimilars (Etanercept, Adalimumab, etc) | Y | Y |
Bispecific Antibodies | Y | Y |
Fc Fusion Proteins | Y | Y |
Diabodies | Y | Y |
Bone Morphogenic Protein (BMP) / Growth Factors | Y | Y |
Interleukin / Cytokines | Y | Y |
Interferon / Cytokines | Y | Y |
Erythropoietin (EPO) | Y | N |
Insulin-like growth factor (IGF) | Y | N |
Transforming growth factor alpha(TGF-α) | Y | Y |
Tumor necrosis factor-alpha(TNF-α) | Y | Y |
Vascular endothelial growth factor (VEGF) | Y | Y |
Glial cell line-derived neurotrophic factor (GDNF) | Y | N |
Protein - Oral Delivery | Y | Y |
Peptide - Oral Delivery | Y | Y |
Collagen Type I | Y | Y |
Collagen Type VII | Y | N |
PEGylated Proteins ( Lys / Cys ) | Y | Y |
IgG4 Products | Y | Y |
Isolation F(ab')2 | Y | N |
Adenovirus Vaccine Products | Y | N |
HIV Recombinant Protein Vaccine | Y | N |
RSV-F Recombinant Protein Vaccine | Y | N |
Plant-Derived Recombinant Proteins | Y | Y |
Glutaraldehyde Crosslinked Proteins | Y | N |
Proteins w/ Glycosylphosphatidylinositol (GPI) Anchor | Y | N |
Lecithin-cholesterol acyltransferase (LCAT) | Y | N |
Bacculovirus Derived Recombinant Proteins | Y | N |
Peptide (Liposomal) Products | Y | Y |
Small Molecule (Liposomal) Products | Y | Y |
H1N1 Recombinant Protein Vaccine | Y | N |
Cross linked Hemoglobin Product(s) | Y | Y |
Recombinant Compliment Factor H | Y | Y |
Peptide Detection in Human Plasma | Y | Y |
Human Anti-thrombin III (ATIII) | Y | N |
Recombinant Human serum amyloid P component (SAP) | Y | N |
Sialylated Intravenous Immunoglobulin (sIVIG) | Y | Y |
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) | Y | N |
Human activated protein C (APC) | Y | N |
Avastin (Bevacizumab) Biosimilar | Y | N |
Enbrel (Etanercept) Biosimilar | Y | Y |
Copaxone (Glatiramer acetate) Biosimilar | Y | Y |
Humira (Adilimumab) Biosimilar | Y | Y |
Remicade (Infliximab) Biosimilar | Y | N |
Herceptin (Trastuzumab) Biosimilar | Y | Y |
Rituxan (Rituximab) Biosimilar | Y | N |
Neupogen (Filgrastim) Biosimilar | Y | Y |
Epogen (Erythropoietin) Biosimilar | Y | N |
Heparan Sulfate: Detection in Urine, CSF, Plasma | Y | Y |
Single Chain Fragments (scFv) | Y | N |
IgG2 Antibodies | Y | N |
Human Acid Ceramidase (hAC) | Y | N |
Corium Analysis | Y | N |
Plasmid DNA Vaccines | Y | N |
Poster
Poster